Friday, February 01, 2013 8:38:29 AM
With substantial dilution on the way I can understand why they are doing their best to convince others to buy the stock in an attempt to spike it again. I just don't see any upside until the terms of the next secondary offering is announced.
The company had indicated at the One Med Forum (posted on the site) that it was seeking a $1,000,000 bridge loan as it attempted to secure $15,000,000 in additional funding.
I can't imagine investors investing $15,000,000 without getting a share price in the .05-.06 range.
All imho.
p.s. Typically the market discounts 30% from the offering price which would be in the .035 range.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM